Stifel Nicolaus Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOC) had its price objective cut by equities research analysts at Stifel Nicolaus from $8.00 to $6.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “hold” rating on the health services provider’s stock. Stifel Nicolaus’ price objective would suggest a potential upside of 12.59% from the company’s current price.

TDOC has been the subject of a number of other reports. Barclays began coverage on shares of Teladoc Health in a research report on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 price target for the company. Citigroup reduced their target price on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Friday, January 9th. Zacks Research downgraded shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Bank of America cut their price target on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 25th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $8.96.

Teladoc Health Stock Performance

TDOC traded up $0.68 on Thursday, reaching $5.33. 4,661,812 shares of the stock were exchanged, compared to its average volume of 6,429,081. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The company’s 50-day moving average price is $6.06 and its 200 day moving average price is $7.22. The firm has a market capitalization of $945.74 million, a PE ratio of -4.16 and a beta of 2.12. Teladoc Health has a fifty-two week low of $4.40 and a fifty-two week high of $10.02.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The business had revenue of $642.27 million for the quarter, compared to analyst estimates of $635.33 million. During the same period in the prior year, the company earned ($0.28) earnings per share. The company’s revenue was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. As a group, sell-side analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity

In related news, CEO Charles Divita III sold 17,138 shares of Teladoc Health stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the completion of the transaction, the chief executive officer owned 201,036 shares in the company, valued at $1,533,904.68. The trade was a 7.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Fernando M. Rodrigues sold 4,209 shares of the company’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total value of $31,483.32. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 33,288 shares of company stock worth $251,684. 0.58% of the stock is currently owned by insiders.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Teacher Retirement System of Texas raised its stake in shares of Teladoc Health by 5.7% during the 2nd quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider’s stock worth $232,000 after buying an additional 1,431 shares during the period. Federated Hermes Inc. increased its holdings in Teladoc Health by 0.5% in the 3rd quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider’s stock worth $2,379,000 after acquiring an additional 1,450 shares in the last quarter. Creative Planning raised its position in Teladoc Health by 7.7% during the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after acquiring an additional 1,462 shares during the period. Krane Funds Advisors LLC lifted its holdings in Teladoc Health by 13.4% during the third quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider’s stock valued at $106,000 after purchasing an additional 1,469 shares in the last quarter. Finally, State of Wyoming grew its position in shares of Teladoc Health by 2.1% in the third quarter. State of Wyoming now owns 79,075 shares of the health services provider’s stock valued at $611,000 after purchasing an additional 1,628 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.